These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1666199)
1. Platelet alpha-2 adrenoreceptor activity pre-treatment and post-treatment in major depressive disorder with melancholia. Bhatia SC; Hsieh HH; Theesen KA; Townley RG; Andersen JM; Weiss S; Agrawal DK Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):47-57. PubMed ID: 1666199 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers. Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152 [TBL] [Abstract][Full Text] [Related]
3. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. Piletz JE; Halaris A; Nelson J; Qu Y; Bari M J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655 [TBL] [Abstract][Full Text] [Related]
4. Adinazolam--a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression. Dunner D; Myers J; Khan A; Avery D; Ishiki D; Pyke R J Clin Psychopharmacol; 1987 Jun; 7(3):170-2. PubMed ID: 3298327 [TBL] [Abstract][Full Text] [Related]
5. [The baseline EEG traits and the induced EEG changes by chronic antidepressant medication in patients with major depression. Early prediction of clinical outcomes solely based on quantification and mapping of EEG]. Ohashi Y Seishin Shinkeigaku Zasshi; 1994; 96(6):444-60. PubMed ID: 7938309 [TBL] [Abstract][Full Text] [Related]
6. Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina. Mehta J; Mehta P; Ostrowski N J Lab Clin Med; 1985 Dec; 106(6):661-6. PubMed ID: 2866219 [TBL] [Abstract][Full Text] [Related]
7. Alpha-adrenoceptor number and function in platelets from treated and untreated patients with essential hypertension and age- and sex-matched controls. Jones CR; Elliott HL; Deighton N; Howie CA; Reid JL J Hypertens Suppl; 1985 Dec; 3(3):S153-5. PubMed ID: 2856816 [TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. Fawcett J; Barkin RL J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155 [TBL] [Abstract][Full Text] [Related]
9. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation. Ansseau M; Devoitille JM; Papart P; Vanbrabant E; Mantanus H; Timsit-Berthier M J Clin Psychopharmacol; 1991 Jun; 11(3):160-5. PubMed ID: 2066454 [TBL] [Abstract][Full Text] [Related]
10. Comparison of adinazolam, amitriptyline, and placebo in the treatment of melancholic depression. Hicks F; Robins E; Murphy GE Psychiatry Res; 1988 Feb; 23(2):221-7. PubMed ID: 3283804 [TBL] [Abstract][Full Text] [Related]
11. Platelet alpha 2-adrenergic receptor sensitivity in major depressive disorder. Stahl SM; Lemoine PM; Ciaranello RD; Berger PA Psychiatry Res; 1983 Nov; 10(3):157-64. PubMed ID: 6320244 [TBL] [Abstract][Full Text] [Related]
13. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder. Feighner JP Psychopharmacol Bull; 1986; 22(1):186-91. PubMed ID: 3523576 [No Abstract] [Full Text] [Related]
14. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation. Lanza F; Cazenave JP Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor. Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829 [TBL] [Abstract][Full Text] [Related]
16. [Antidepressant drugs and central monoaminergic receptors]. Asakura M; Tsukamoto T Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595 [TBL] [Abstract][Full Text] [Related]
17. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Neubig RR; Gantzos RD; Brasier RS Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672 [TBL] [Abstract][Full Text] [Related]
18. Binding of yohimbine and imipramine to platelets in depressive illness. Braddock L; Cowen PJ; Elliott JM; Fraser S; Stump K Psychol Med; 1986 Nov; 16(4):765-73. PubMed ID: 3029789 [TBL] [Abstract][Full Text] [Related]
19. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Feighner JP J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204 [TBL] [Abstract][Full Text] [Related]
20. Yohimbine and clonidine recognize different states of adrenergic receptors on human platelets: reconsideration of studies on platelet alpha-2 receptors in depressive illness. Piletz JE; Halaris A Psychopharmacol Bull; 1985; 21(3):573-8. PubMed ID: 2994160 [No Abstract] [Full Text] [Related] [Next] [New Search]